{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:58:54Z","timestamp":1774317534043,"version":"3.50.1"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejso.2017.10.215","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T14:09:39Z","timestamp":1510582179000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: A\u00a0comprehensive review of current data"],"prefix":"10.1016","volume":"44","author":[{"given":"Petros","family":"Charalampoudis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Markopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejso.2017.10.215_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF02967528","article-title":"Adjuvant therapy for breast cancer\u2013results from the USA consensus conference","volume":"8","author":"Abrams","year":"2001","journal-title":"Breast Cancer Tokyo Jpn"},{"issue":"5","key":"10.1016\/j.ejso.2017.10.215_bib2","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1245\/s10434-008-9863-8","article-title":"Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach","volume":"15","author":"Samphao","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2017.10.215_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy\u00a0versus standard axillary treatment in operable breast cancer: the ALMANAC Trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ejso.2017.10.215_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/SLA.0b013e31812e6a73","article-title":"A\u00a0Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella\/GIVOM trial","volume":"247","author":"Zavagno","year":"2008","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.ejso.2017.10.215_bib5","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1245\/s10434-016-5177-4","article-title":"Sentinel lymph node biopsy versus axillary dissection in node-negative early-stage breast cancer: 15-year follow-up update of a randomized clinical trial","volume":"23","author":"Canavese","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2017.10.215_bib6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A\u00a0randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ejso.2017.10.215_bib7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2017.10.215_bib8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0011-3840(98)80008-7","article-title":"Minimal access surgery for staging regional lymph nodes: the sentinel-node concept","volume":"35","author":"Krag","year":"1998","journal-title":"Curr Probl Surg"},{"issue":"14","key":"10.1016\/j.ejso.2017.10.215_bib9","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJM199810013391401","article-title":"The sentinel node in breast cancer\u2013a multicenter validation study","volume":"339","author":"Krag","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"9069","key":"10.1016\/j.ejso.2017.10.215_bib10","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","article-title":"Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes","volume":"349","author":"Veronesi","year":"1997","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.ejso.2017.10.215_bib11","article-title":"Axillary treatment for operable primary breast cancer","volume":"04","author":"Bromham","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ejso.2017.10.215_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10549-009-0705-6","article-title":"Outcome of axillary staging\u00a0in early breast cancer: a meta-analysis","volume":"120","author":"Kell","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.ejso.2017.10.215_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10549-011-1665-1","article-title":"Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis","volume":"129","author":"Wang","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.ejso.2017.10.215_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","article-title":"Post-operative arm morbidity and quality of life. Results\u00a0of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer","volume":"95","author":"Fleissig","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.ejso.2017.10.215_bib15","first-page":"508","article-title":"Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical\u00a0trial","volume":"34","author":"Del Bianco","year":"2008","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2017.10.215_bib16","first-page":"1277","article-title":"Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature","volume":"34","author":"van der Ploeg","year":"2008","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol\u00a0Br Assoc Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2017.10.215_bib17","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/annonc\/mdn746","article-title":"Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial","volume":"20","author":"Canavese","year":"2009","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2017.10.215_bib18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients\u00a0with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2017.10.215_bib19","first-page":"69","article-title":"Staging the axilla in women with breast cancer: the utility of preoperative ultrasound-guided needle biopsy","volume":"11","author":"Houssami","year":"2014","journal-title":"Cancer Biol Med"},{"issue":"3","key":"10.1016\/j.ejso.2017.10.215_bib20","first-page":"1087","article-title":"Clinical utility of ultrasound-needle biopsy for preoperative staging of the axilla in invasive breast cancer","volume":"34","author":"Houssami","year":"2014","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.ejso.2017.10.215_bib21","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.breast.2013.09.002","article-title":"Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?","volume":"22","author":"Schipper","year":"2013","journal-title":"Breast Edinb Scotl"},{"issue":"2","key":"10.1016\/j.ejso.2017.10.215_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SLA.0b013e31821f1564","article-title":"Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla","volume":"254","author":"Houssami","year":"2011","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ejso.2017.10.215_bib23","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/SLA.0000000000001549","article-title":"Axillary ultrasound accurately excludes clinically significant lymph node disease in patients with early stage breast cancer","volume":"264","author":"Tucker","year":"2016","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2017.10.215_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jss.2015.03.057","article-title":"Predictors of false negative axillary ultrasound in breast cancer","volume":"198","author":"Nwaogu","year":"2015","journal-title":"J\u00a0Surg Res"},{"issue":"6","key":"10.1016\/j.ejso.2017.10.215_bib25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ejso.2017.10.215_bib26","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1007\/s00330-015-3683-6","article-title":"The Z0011 Trial: is this the end of axillary ultrasound\u00a0in the pre-operative assessment of breast cancer patients?","volume":"25","author":"Farrell","year":"2015","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.ejso.2017.10.215_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2013.07.017","article-title":"Preoperative axillary imaging with percutaneous lymph node biopsy\u00a0is valuable in the contemporary management of patients with breast cancer","volume":"154","author":"Hieken","year":"2013","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.ejso.2017.10.215_bib28","first-page":"559","article-title":"Axillary nodal burden in primary breast cancer patients\u00a0with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011","volume":"41","author":"Boland","year":"2015","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2017.10.215_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10549-017-4405-3","article-title":"Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients","volume":"166","author":"Ahmed","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.ejso.2017.10.215_bib30","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1245\/s10434-015-4944-y","article-title":"Does a positive axillary lymph node needle biopsy result predict the need for an axillary lymph node dissection in clinically node-negative breast cancer patients in the ACOSOG Z0011 era?","volume":"23","author":"Pilewskie","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2017.10.215_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jamcollsurg.2015.11.013","article-title":"Is preoperative axillary imaging beneficial in identifying clinically node-negative patients requiring axillary lymph node dissection?","volume":"222","author":"Pilewskie","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"issue":"3","key":"10.1016\/j.ejso.2017.10.215_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2017.10.215_bib33","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","article-title":"Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: sentinel node vs Observation after axillary UltraSouND)","volume":"21","author":"Gentilini","year":"2012","journal-title":"Breast Edinb Scotl"},{"issue":"1","key":"10.1016\/j.ejso.2017.10.215_bib34","first-page":"8","article-title":"Sentinel lymph node biopsy after previous axillary surgery: a review","volume":"38","author":"Kothari","year":"2012","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2017.10.215_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-013-2409-1","article-title":"Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature","volume":"138","author":"Maaskant-Braat","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.ejso.2017.10.215_bib36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10549-015-3571-4","article-title":"Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer","volume":"153","author":"Vugts","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2017.10.215_bib37","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update","author":"Lyman","year":"2016","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2017.10.215_bib38","first-page":"688","article-title":"Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer","volume":"8","author":"Chung","year":"2001","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2017.10.215_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9610(02)01057-7","article-title":"Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers","volume":"67","author":"Wong","year":"2001","journal-title":"Am Surg"},{"issue":"3","key":"10.1016\/j.ejso.2017.10.215_bib40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijsu.2009.04.012","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory\u00a0breast cancer","volume":"7","author":"Hidar","year":"2009","journal-title":"Int J Surg Lond Engl"},{"issue":"4","key":"10.1016\/j.ejso.2017.10.215_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.6004\/jnccn.2017.0044","article-title":"NCCN guidelines insights: breast cancer, version 1.2017","volume":"15","author":"Gradishar","year":"2017","journal-title":"J\u00a0Natl Compr Cancer Netw JNCCN"},{"issue":"8","key":"10.1016\/j.ejso.2017.10.215_bib42","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamaoncol.2015.2413","article-title":"Breast cancer diagnosed during pregnancy: Adapting recent advances in breast cancer care for pregnant patients","volume":"1","author":"Loibl","year":"2015","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2017.10.215_bib43","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/annonc\/mdh355","article-title":"Safety of sentinel node biopsy in pregnant patients\u00a0with breast cancer","volume":"15","author":"Gentilini","year":"2004","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2017.10.215_bib44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00259-009-1217-7","article-title":"Sentinel lymph node biopsy in pregnant patients with breast cancer","volume":"37","author":"Gentilini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.ejso.2017.10.215_bib45","first-page":"1202","article-title":"Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients","volume":"47","author":"Pandit-Taskar","year":"2006","journal-title":"J\u00a0Nucl Med Off Publ Soc Nucl Med"},{"issue":"1","key":"10.1016\/j.ejso.2017.10.215_bib46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.amjsurg.2009.03.013","article-title":"Pharmacokinetics of methylene blue dye for lymphatic mapping\u00a0in breast cancer-implications for use in pregnancy","volume":"201","author":"Pruthi","year":"2011","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2017.10.215_bib47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2004.99.276","article-title":"Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis","volume":"22","author":"Raut","year":"2004","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"Suppl. 28","key":"10.1016\/j.ejso.2017.10.215_bib48","article-title":"Age, race, BMI, and pathologic complete response following neoadjuvant chemotherapy: an analysis of four alliance clinical trials","volume":"33","author":"Ballman","year":"2015","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2017.10.215_bib49","first-page":"755","article-title":"Neoadjuvant breast cancer therapy and drug development","volume":"13","author":"Cortazar","year":"2015","journal-title":"Clin Adv Hematol Oncol HO"},{"issue":"12","key":"10.1016\/j.ejso.2017.10.215_bib50","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s40265-017-0774-5","article-title":"Neoadjuvant therapy for breast cancer: established concepts and emerging strategies","volume":"77","author":"Steenbruggen","year":"2017","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.ejso.2017.10.215_bib51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.5209","article-title":"Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer","volume":"93","author":"Xing","year":"2006","journal-title":"Br J Surg"},{"issue":"11","key":"10.1016\/j.ejso.2017.10.215_bib52","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/1097-0142(20001201)89:11<2187::AID-CNCR6>3.0.CO;2-#","article-title":"Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma","volume":"89","author":"Nason","year":"2000","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2017.10.215_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1524-4741.2002.08205.x","article-title":"Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer","volume":"8","author":"Brady","year":"2002","journal-title":"Breast J"},{"issue":"5","key":"10.1016\/j.ejso.2017.10.215_bib54","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle\u00a0et Chimiotherapie Neoadjuvante, a French prospective multicentric study","volume":"27","author":"Classe","year":"2009","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2017.10.215_bib55","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients","volume":"250","author":"Hunt","year":"2009","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2017.10.215_bib56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jso.21911","article-title":"The feasibility and accuracy of sentinel lymph node biopsy\u00a0in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer\u2013a systematic review and meta-analysis","volume":"104","author":"Tan","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2017.10.215_bib57","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.acra.2009.01.026","article-title":"Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis","volume":"16","author":"Kelly","year":"2009","journal-title":"Acad Radiol"},{"issue":"6","key":"10.1016\/j.ejso.2017.10.215_bib58","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1200\/JCO.2013.53.4974","article-title":"Locoregional radiotherapy in patients with breast cancer responding to neoadjuvant chemotherapy: a paradigm for treatment individualization","volume":"32","author":"White","year":"2014","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2017.10.215_bib59","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","article-title":"Axillary nodal management following neoadjuvant chemotherapy: a review","volume":"3","author":"Pilewskie","year":"2017","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2017.10.215_bib60","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.ejso.2017.10.215_bib61","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ejso.2017.10.215_bib62","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2017.10.215_bib63","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-017-4164-1","article-title":"Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer","volume":"163","author":"Zetterlund","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.ejso.2017.10.215_bib64","first-page":"657","article-title":"Postmastectomy radiotherapy after neoadjuvant chemotherapy: a review of the evidence","volume":"29","author":"Chapman","year":"2015","journal-title":"Oncol Willist Park N"},{"issue":"2","key":"10.1016\/j.ejso.2017.10.215_bib65","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment\u00a0in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2017.10.215_bib66","article-title":"Feasibility of preoperative axillary lymph node marking with a clip in breast cancer patients before neoadjuvant chemotherapy: a preliminary study","author":"Kim","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2017.10.215_bib67","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-017-6023-z","article-title":"Localizing the clipped node in patients with node-positive breast cancer treated with neoadjuvant chemotherapy: early learning experience and challenges","author":"Nguyen","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2017.10.215_bib68","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","article-title":"Finding the balance between over-\u00a0and under-treatment of ductal carcinoma in situ (DCIS)","volume":"31","author":"Groen","year":"2017","journal-title":"Breast Edinb Scotl"},{"issue":"6","key":"10.1016\/j.ejso.2017.10.215_bib69","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.ejso.2017.10.215_bib70","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1177\/000313481608201027","article-title":"Is sentinel lymph node dissection necessary in all patients with ductal carcinoma in situ undergoing total mastectomy?","volume":"82","author":"Bonev","year":"2016","journal-title":"Am Surg"},{"issue":"1","key":"10.1016\/j.ejso.2017.10.215_bib71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1754-9485.12503","article-title":"Ductal carcinoma in situ: is core needle biopsy ever enough?","volume":"61","author":"Caswell-Smith","year":"2017","journal-title":"J\u00a0Med Imaging Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2017.10.215_bib72","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12893-017-0210-5","article-title":"DCIS and axillary nodal evaluation: compliance with national guidelines","volume":"17","author":"Mitchell","year":"2017","journal-title":"BMC Surg"},{"issue":"5","key":"10.1016\/j.ejso.2017.10.215_bib73","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/bjs.6162","article-title":"Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast","volume":"95","author":"Ansari","year":"2008","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2017.10.215_bib74","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.clbc.2016.10.002","article-title":"Sentinel node procedure obsolete in lumpectomy for ductal carcinoma in situ","volume":"17","author":"Heymans","year":"2017","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2017.10.215_bib75","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10549-016-3783-2","article-title":"Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy","volume":"156","author":"van Roozendaal","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.ejso.2017.10.215_bib76","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1245\/s10434-016-5145-z","article-title":"Is sentinel lymph node biopsy indicated at completion mastectomy for ductal carcinoma in situ?","volume":"23","author":"Pilewskie","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2017.10.215_bib77","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/cncr.11761","article-title":"The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up","volume":"98","author":"Lara","year":"2003","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2017.10.215_bib78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.breast.2015.01.004","article-title":"Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast","volume":"24","author":"Prendeville","year":"2015","journal-title":"Breast Edinb Scotl"},{"issue":"5","key":"10.1016\/j.ejso.2017.10.215_bib79","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1245\/s10434-009-0397-5","article-title":"Sentinel node biopsy in breast cancer patients with large or multifocal tumors","volume":"16","author":"Meretoja","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"21","key":"10.1016\/j.ejso.2017.10.215_bib80","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1200\/JCO.2006.05.7372","article-title":"Multicentric breast cancer: a new indication for sentinel node biopsy\u2013a multi-institutional validation study","volume":"24","author":"Knauer","year":"2006","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2017.10.215_bib81","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2017.10.215_bib82","first-page":"2093","article-title":"Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcome","volume":"49","author":"Donker","year":"2013","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"6","key":"10.1016\/j.ejso.2017.10.215_bib83","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jnci\/djq008","article-title":"Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases","volume":"102","author":"de Boer","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.ejso.2017.10.215_bib84","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1008108","article-title":"Effect of occult metastases on survival in node-negative breast cancer","volume":"364","author":"Weaver","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ejso.2017.10.215_bib85","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jamcollsurg.2008.10.036","volume":"208","author":"Reed","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"issue":"10","key":"10.1016\/j.ejso.2017.10.215_bib86","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1245\/s10434-010-1062-8","article-title":"Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)]","volume":"17","author":"Degnim","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2017.10.215_bib87","first-page":"690","article-title":"When is a completion axillary lymph node dissection necessary in the presence of a positive sentinel lymph node?","volume":"50","author":"Suyoi","year":"2014","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"9","key":"10.1016\/j.ejso.2017.10.215_bib88","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1200\/JCO.2009.26.7575","article-title":"Micrometastases and isolated tumor cells in breast cancer are indeed associated with poorer outcome","volume":"28","author":"van Diest","year":"2010","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2017.10.215_bib89","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa0904832","article-title":"Micrometastases or isolated tumor cells and the outcome of breast cancer","volume":"361","author":"de Boer","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ejso.2017.10.215_bib90","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2011.1034","article-title":"Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer","volume":"306","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejso.2017.10.215_bib91","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10549-017-4157-0","article-title":"Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases","volume":"163","author":"van Nijnatten","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ejso.2017.10.215_bib92","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000","volume":"20","author":"Sol\u00e1","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2017.10.215_bib93","first-page":"672","article-title":"Eight-year follow up result of the OTOASOR trial: the Optimal Treatment of the Axilla - surgery or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"S\u00e1volt","year":"2017","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2017.10.215_bib94","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2017.10.215_bib95","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.clon.2015.07.005","article-title":"POSNOC: A randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases","volume":"27","author":"Goyal","year":"2015","journal-title":"Clin Oncol R Coll Radiol G. B"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317309551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317309551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:23:59Z","timestamp":1760059439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798317309551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0748798317309551"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2017.10.215","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: A\u00a0comprehensive review of current data","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2017.10.215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}